Applied DNA Sciences, Inc. (BNBX) — Financial Flexibility Index
Applied DNA Sciences, Inc. (BNBX) has a Financial Flexibility Index of -1.36x as of March 2026. Free cash flow of $-2.05 Million (operating CF $-2.05 Million minus capex $3.00) represents -1% of total liabilities ($1.50 Million). Check BNBX tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Applied DNA Sciences, Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Applied DNA Sciences, Inc. across 5 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Applied DNA Sciences, Inc..
Annual Financial Flexibility Index for Applied DNA Sciences, Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Applied DNA Sciences, Inc.. Explore cash flow to debt ratio of Applied DNA Sciences, Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.89x | $-12.21 Million | $-12.52 Million | $2.50 Million | ▼ -40.5% |
| 2024 | -3.48x | $-13.30 Million | $-13.71 Million | $3.82 Million | ▼ -397.9% |
| 2023 | -0.70x | $-6.14 Million | $-6.22 Million | $8.78 Million | ▲ +22.9% |
| 2022 | -0.91x | $-8.49 Million | $-8.98 Million | $9.36 Million | ▲ +72.4% |
| 2021 | -3.28x | $-10.84 Million | $-13.39 Million | $3.30 Million | — |